Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Han-Sang Baek"'
Autor:
Han-Sang Baek, Jeonghoon Ha, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim, Sungju Kim, Dong-Jun Lim, Chul-Min Kim
Publikováno v:
Endocrinology and Metabolism, Vol 39, Iss 2, Pp 310-323 (2024)
Background There is debate about ultrasonography screening for thyroid cancer and its cost-effectiveness. This study aimed to evaluate the cost-effectiveness of early screening (ES) versus symptomatic detection (SD) for differentiated thyroid cancer
Externí odkaz:
https://doaj.org/article/b522d40261a24557bbc087340eadf9db
Autor:
Han-Sang Baek, Bongseong Kim, Seung-Hwan Lee, Dong-Jun Lim, Hyuk-Sang Kwon, Sang-Ah Chang, Kyungdo Han, Jae-Seung Yun
Publikováno v:
Endocrinology and Metabolism, Vol 38, Iss 6, Pp 770-781 (2023)
Background Elevated γ-glutamyl transferase (γ-GTP) levels are associated with metabolic syndrome. We investigated the association of cumulative exposure to high γ-GTP with the risk of cardiovascular disease (CVD) in a large-scale population. Metho
Externí odkaz:
https://doaj.org/article/0b03ab37663843da8f53b738164532d5
Autor:
Jin Yu, Han-Sang Baek, Chaiho Jeong, Kwanhoon Jo, Jeongmin Lee, Jeonghoon Ha, Min Hee Kim, Jungmin Lee, Dong-Jun Lim
Publikováno v:
Endocrinology and Metabolism, Vol 38, Iss 3, Pp 338-346 (2023)
Background To determine whether baseline thyroid-stimulating immunoglobulin (TSI) bioassay or its early response upon treatment with an anti-thyroid drug (ATD) can predict prognosis of Graves’ disease (GD) in real-world practice. Methods This retro
Externí odkaz:
https://doaj.org/article/d5d4814e35854a6eae5458409f5fec5a
Publikováno v:
Current Oncology, Vol 30, Iss 3, Pp 3020-3031 (2023)
Recently, selpercatinib, a highly selective inhibitor of RET receptor tyrosine kinase, has been used for RET-altered thyroid cancer. We present four cases of patients with advanced thyroid cancer who were treated with selpercatinib. The first patient
Externí odkaz:
https://doaj.org/article/995c5dce635a4a9089e33b6f9572379f
Autor:
Han-sang Baek, Ji-Yeon Park, Jin Yu, Joonyub Lee, Yeoree Yang, Jeonghoon Ha, Seung Hwan Lee, Jae Hyoung Cho, Dong-Jun Lim, Hun-Sung Kim
Publikováno v:
Endocrinology and Metabolism, Vol 37, Iss 4, Pp 641-651 (2022)
Background The prevalence of young-onset diabetes (YOD) has been increasing worldwide. As the incidence of YOD increases, it is necessary to determine the characteristics of YOD and the factors that influence its development and associated complicati
Externí odkaz:
https://doaj.org/article/51f6b258990e472abe77bdf033292bfb
Publikováno v:
Endocrinology and Metabolism, Vol 37, Iss 2, Pp 323-332 (2022)
Background Microvascular ultrasonography (MVUS) is a third-generation Doppler technique that was developed to increase sensitivity compared to conventional Doppler. The purpose of this study was to compare MVUS with conventional color Doppler (CD) an
Externí odkaz:
https://doaj.org/article/7e5a189569424369ac89027fe4d646ca
Autor:
Han-sang Baek, Chaiho Jeong, Kabsoo Shin, Jaejun Lee, Heysun Suh, Dong-Jun Lim, Moo Il Kang, Jeonghoon Ha
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Immune checkpoint inhibitors (ICIs) cause thyroid immune-related adverse effects (irAEs). However, associations between each type of thyroid immune-related adverse effect (irAE) and the anti-tumor effect of ICI remains unknown. Th
Externí odkaz:
https://doaj.org/article/ef4155d5398a4835999fdbffdd3621b7
Publikováno v:
Endocrinology and Metabolism, Vol 36, Iss 5, Pp 1095-1110 (2021)
Background Peroxisome proliferator-activated receptor-gamma (PPAR-γ) ligands have been widely shown to correlate with epithelial-mesenchymal transition (EMT) and cancer progression. Lobeglitazone (LGZ) is a novel ligand of PPAR-γ; and its role in E
Externí odkaz:
https://doaj.org/article/16db20e58ac244a4a895be47540c43f2
Autor:
Jinyoung Kim, Han-Sang Baek, Jeonghoon Ha, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Dong-Jun Lim, Ki-Hyun Baek
Publikováno v:
Diagnostics, Vol 12, Iss 6, p 1468 (2022)
Differential diagnosis of thyrotoxicosis is essential because therapeutic approaches differ based on disease etiology. We aimed to perform differential diagnosis of thyrotoxicosis using machine learning algorithms with initial laboratory findings. Th
Externí odkaz:
https://doaj.org/article/6d6b4d223ddc4e16885b2505ef510809
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.